DSpace Repository

Biological toxicity of nanoparticles

Show simple item record

dc.contributor.author Taliyan, Rajeev
dc.date.accessioned 2023-12-13T08:50:41Z
dc.date.available 2023-12-13T08:50:41Z
dc.date.issued 2022
dc.identifier.uri https://www.sciencedirect.com/science/article/abs/pii/B9780128207574000168
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13396
dc.description.abstract Multiple biological barriers and discrepancy in releasing the optimal dosage range pose a great challenge in the current therapeutic management for majority of diseases. Nanoparticle drug delivery system (5–250 nm) possesses the capacity to overcome such difficulties making it an incredible choice for disease management. Various types of nanoparticles are readily available in the market each possessing its own unique characteristics, however, based on their size, shape, and surface reactivity, they can inflict certain type of toxicity, the most common being biological toxicity to human tissue and to cell culture. The toxicity can further lead to an enhanced level of oxidative stress and inflammatory cytokine. Hence, in the following chapter, we discuss the various types of nanoparticles available, its importance in the clinical field and a detailed understanding on the biological toxicity of nanoparticles. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Pharmacy en_US
dc.subject Nanoparticle drug delivery system en_US
dc.title Biological toxicity of nanoparticles en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account